市場調查報告書 - 119574

全球的體外照射療法市場：2010年

Market Agent: 2011 GLOBAL MARKETS FOR EXTERNAL RADIATION THERAPY
出版商 Life Science Intelligence, Inc.
出版日期 2011年05月01日 內容資訊 英文
價格
全球的體外照射療法市場：2010年 Market Agent: 2011 GLOBAL MARKETS FOR EXTERNAL RADIATION THERAPY
出版日期: 2011年05月01日 內容資訊: 英文
簡介

本報告書內容包括:全球的體外照射療法市場的相關整體市場整合解決方案。高品質且詳細的最新資料及每6個月定期更新的最新資料等提供。

第1章 既存的技術和特徴和新興技術

  • 既存技術的特徴
  • 既存技術的課題
    • 適合性
    • 無酸素組織
      • 經濟的要因
        • 補助和國家的政策及計畫
        • 系統價格和相關費用
        • 全球經濟

第2章 美國的體外照射療法市場

  • 市場預測：2007∼2013年
  • 供應商佔有率：2008年
  • 線形加速器及伽碼射線設備市場的影響因素
  • 美國的體外照射療法：線形加速器及伽碼射線設備：2007∼2013年
  • 美國的線形加速器及伽碼射線設備佔有率：2008年
  • 美國的各種系統市場預測：2007∼2013年
  • 線形加速器及伽碼射線設備：2008年及2013年
  • 不景氣的影響：線形加速器及伽碼射線設備
  • 體外照射療法和SRS市場：2007∼2013年
  • 體外照射療法和SRS市場的影響因素：2007∼2013年
  • 各種用途市場預測：2007∼2013年
  • SRS及體外照射療法設備：2008年及2013年
  • 不景氣的影響：SRS設備
  • 定位性放射線治療：美國患者人數：2007∼2013年
  • 定位性放射線治療：美國各種類患者趨勢：2007∼2013年
  • 頭蓋外定位性放射線治療：美國患者人數：2007∼2013年
  • 定位性放射線治療：美國的處理件數：2007∼2013年
  • 定位性放射線治療：美國的各種類處理件數：2007∼2013年
  • 不景氣的影響：頭蓋外定位性放射線治療
  • 體外照射療法所治療的乳癌・肺癌・前列腺癌患者數：2007∼2013年
  • 陽子線治療：美國市場預測：2007∼2013年
  • 陽子線治療設備：美國供應商佔有率：2008年
  • 陽子線治療：患者趨勢：2007∼2013年
  • 陽子線治療：美國處理件數：2007∼2013年

第3章 美國以外的體外照射療法市場

第4章 合併・收購・聯盟

第5章 新興企業

目錄

Abstract

“2011 GLOBAL MARKETS FOR EXTERNAL RADIATION THERAPY” is a comprehensive, total market intelligence solution designed for senior executives who are looking for:

  • High quality, granular, deeply segmented data
  • Access to senior LSI analysts to conduct proprietary modeling and custom market simulations
  • Access to useable source data for in-house customization and adoption of market models

This product is a complete market intelligence solution.

The deliverables include:

  • Initial report with most recent data available (PDF and Excel)
  • Extensive access to senior LSI analyst for proprietary add-on analysis
  • Online platform making the data useable and interactive

About Life Science Intelligence

Life Science Intelligence (LSI) delivers high quality market reports, market agents, procedure databases, company databases, online partnering events, and custom consulting services to medical technology executives, investors, and entrepreneurs. LSI produces its own information products and partners with select top-tier information companies to distribute their products.

Table of Contents

1. ESTABLISHED AND EMERGING TECHNOLOGIES

  • 1.1. Features of Established Technologies
  • 1.2. Challenges for Established Technologies
    • 1.2.1. Conformality
    • 1.2.2. Anoxic Tissues
      • 1.2.2.1. Economic Factors
        • 1.2.2.1.1. Reimbursement and National Policies and Initiatives
        • 1.2.2.1.2. System Prices & Associated Costs
        • 1.2.2.1.3. The Global Economy
  • Exhibit 1-1: External Radiation Therapy by Type
  • Exhibit 1-2: Advantages and Disadvantages of External Radiation Therapy Systems
  • Exhibit 1-3: Features of Linear Accelerator and Gamma-Ray Systems Used for External Radiation Therapy and SRS
  • Exhibit 1-4: Features of Particle Therapy Centers
  • Exhibit 1-5: Challenges Associated with Available Technologies
  • Exhibit 1-6: Established and Emerging Technologies

2. U.S. MARKETS FOR EXTERNAL RADIATION THERAPY

  • Exhibit 2-1: External Radiation Therapy, U.S. Market Forecast, 2007-2013
  • Exhibit 2-2: External Radiation Therapy, Supplier Shares, 2008
  • Exhibit 2-3: Factors Influencing the U.S. Market for Linear Accelerator & Gamma-Ray Systems from 2007-2013
  • Exhibit 2-4: U.S. External Radiation Therapy, Linear Accelerators & Gamma-Ray Systems, 2007-2013
  • Exhibit 2-5: Linear Accelerator & Gamma-Ray Systems, U.S. Shares, 2008
  • Exhibit 2-6: U.S. Market Forecast by Type of System, Linear Accelerator and Gamma-Ray Systems, 2007-2013
  • Exhibit 2-7: Linear Accelerator and Gamma-Ray Systems, 2008 & 2013
  • Exhibit 2-8: Impact of the Recession: Gamma-Ray Systems and Linear Accelerators, 2007-2013
  • Exhibit 2-9: Factors Influencing the U.S. Market for External Radiation Therapy and SRS from 2007-2013
  • Exhibit 2-10: External Radiation Therapy, U.S. Market Forecast by Application, 2007-2013
  • Exhibit 2-11: SRS and External Radiation Systems, 2008 & 2013
  • Exhibit 2-12: Impact of the Recession: SRS Systems, 2007-2013
  • Exhibit 2-13: Stereotactic Radiosurgery - U.S. Patient Volumes, 2007-2013
  • Exhibit 2-14: Stereotactic Radiosurgery - U.S. Patient Volumes by Type, 2007-2013
  • Exhibit 2-15: Stereotactic Radiosurgery - Utilization by Patient Type, 2007-2013
  • Exhibit 2-16: Extracranial Stereotactic Radiosurgery - U.S. Patient Volumes, 2007-2013
  • Exhibit 2-17: Stereotactic Radiosurgery - U.S. Procedure Volumes, 2007-2013
  • Exhibit 2-18: Stereotactic Radiosurgery - U.S. Procedures by Type, 2007-2013
  • Exhibit 2-19: Stereotactic Radiosurgery - Utilization by Procedure, 2007-2013
  • Exhibit 2-20: Extracranial Stereotactic Radiosurgery - U.S. Procedure Volumes, 2007-2013
  • Exhibit 2-21: Impact of the Recession: External Radiation Therapy Systems, 2007-2013.
  • Exhibit 2-22: New Cancer Cases in the U.S by Anatomical Location, 2007-2013
  • Exhibit 2-23: Breast, Lung and Prostate Patients Treated with External Radiation Therapy in the U.S., 2007-2013
  • Exhibit 2-24: Other Patients Treated with External Radiation Therapy, 2007-2013
  • Exhibit 2-25: External Radiation Therapy in the U.S., Breast, Lung, and Prostate Procedures, 2007-2013
  • Exhibit 2-26: Other External Radiation Therapy Procedures in the U.S., 2007-2013
  • Exhibit 2-27: Factors Influencing the U.S. Market for Proton Therapy, 2007-2013
  • Exhibit 2-28: Proton Therapy, U.S. Market Forecast, 2007-2013
  • Exhibit 2-29: Proton Therapy Systems, U.S. Supplier Shares in 2008
  • Exhibit 2-30: Proton Therapy, U.S. Patient Volumes, 2007-2013
  • Exhibit 2-31: Proton Therapy, U.S. Procedure Volumes, 2007-2013

3. OUS MARKETS FOR EXTERNAL RADIATION THERAPY

  • Exhibit 3-1: External Radiation Therapy, OUS Market Forecast, 2007-2013
  • Exhibit 3-2: OUS External Radiation Therapy, Supplier Shares, 2008
  • Exhibit 3-3: Factors Influencing the OUS Market for Linear Accelerator & Gamma-Ray Systems from 2007-2013
  • Exhibit 3-4: External Radiation Therapy in Europe, Linear Accelerator & Gamma-Ray Systems, 2007-2013
  • Exhibit 3-5: Linear Accelerator & Gamma-Ray Systems, European Shares in 2008
  • Exhibit 3-6: European Market Forecast by Type of System, Linear Accelerator and Gamma-Ray Systems, 2007-2013
  • Exhibit 3-7: Linear Accelerator and Gamma-Ray Systems in Europe, 2008 & 2013
  • Exhibit 3-8: AP & ROW External Radiation Therapy, Linear Accelerator & Gamma-Ray Systems, 2007-2013
  • Exhibit 3-9: Linear Accelerator & Gamma-Ray Systems, AP & ROW Shares, 2008
  • Exhibit 3-10: AP & ROW Market Forecast by Type of System, Gamma-Ray & Linear Accelerator Systems, 2007-2013
  • Exhibit 3-11: Gamma-Ray & Linear Accelerator Systems in AP&ROW, 2008 & 2013
  • Exhibit 3-12: Factors Influencing the OUS Market for External Radiation Therapy and SRS from 2007-2013
  • Exhibit 3-13: External Radiation Therapy, European Market Forecast by Application, 2007-2013
  • Exhibit 3-14: SRS and External Radiation Systems in Europe, 2008 & 2013
  • Exhibit 3-15: Stereotactic Radiosurgery - European Patient Volumes, 2007-2013
  • Exhibit 3-16: Stereotactic Radiosurgery - European Patient Volumes by Type, 2007-2013
  • Exhibit 3-17: Stereotactic Radiosurgery - Utilization by Patient Type in Europe, 2007-2013
  • Exhibit 3-18: Extracranial Stereotactic Radiosurgery - European Patient Volumes, 2007-2013
  • Exhibit 3-19: Stereotactic Radiosurgery - European Procedure Volumes, 2007-2013
  • Exhibit 3-20: Stereotactic Radiosurgery - European Procedures by Type, 2007-2013
  • Exhibit 3-21: Stereotactic Radiosurgery in Europe - Utilization by Procedure, 2007-2013
  • Exhibit 3-22: Extracranial Stereotactic Radiosurgery - European Procedure Volumes, 2007-2013
  • Exhibit 3-23: Breast, Lung and Prostate Patients Treated with Radiation Therapy in Europe, 2007-2013
  • Exhibit 3-24: Other Patients Treated with External Radiation Therapy in Europe, 2007-2013
  • Exhibit 3-25: External Radiation Therapy in Europe, Breast, Lung, and Prostate Procedures, 2007-2013
  • Exhibit 3-26: Other External Radiation Therapy Procedures in Europe, 2007-2013
  • Exhibit 3-27: External Radiation Therapy, AP & ROW Market Forecast by Application, 2007-2013
  • Exhibit 3-28: Stereotactic Radiosurgery - AP & ROW Patient Volumes, 2007-2013
  • Exhibit 3-29: Stereotactic Radiosurgery - AP & ROW Patient Volumes by Type, 2007-2013
  • Exhibit 3-30: Stereotactic Radiosurgery - AP & ROW Utilization by Type of Patients, 2007-2013
  • Exhibit 3-31: Stereotactic Radiosurgery - AP & ROW Procedure Volumes, 2007-2013
  • Exhibit 3-32: Stereotactic Radiosurgery - AP & ROW Procedures by Type, 2007-2013
  • Exhibit 3-33: Breast, Lung and Prostate Patients Treated with Radiation Therapy in AP & ROW Countries, 2007-2013
  • Exhibit 3-34: Other Patients Treated with External Radiation Therapy in AP & ROW Countries, 2007-2013
  • Exhibit 3-35: External Radiation Therapy in AP & ROW Countries, Breast, Lung, and Prostate Procedures, 2007-2013
  • Exhibit 3-36: Other External Radiation Therapy Procedures in AP & ROW Countries, 2007-2013
  • Exhibit 3-37: Factors Influencing the OUS Market for Particle Therapy, 2007-2013
  • Exhibit 3-38: Particle Therapy, European Market Forecast, 2007-2013
  • Exhibit 3-39: Particle Therapy in Europe by Type, 2007-2013
  • Exhibit 3-40: Particle Therapy Systems, European Supplier Shares in 2008
  • Exhibit 3-41: Particle Therapy, European Patient Volumes, 2007-2013
  • Exhibit 3-42: Particle Therapy, AP & ROW Market Forecast, 2007-2013
  • Exhibit 3-43: Particle Therapy in Europe by Type, 2007-2013
  • Exhibit 3-44: Particle Therapy Systems, AP & ROW Supplier Shares in 2008
  • Exhibit 3-45: Particle Therapy, AP & ROW Patient Volumes, 2007-2013

4. MERGERS, ACQUISITIONS, AND PARTNERSHIPS

5. EMERGING COMPANIES

全球的體外照射療法市場：2010年是由出版商Life Science Intelligence, Inc.在2011年05月01日所出版的。這份市場調查報告書價格從美金6500起跳。
Back to Top
;